Startups

xpander launches a vendor-neutral control plane for the AI agent sprawl

Higgsfield AI Raises $400M at $5.4B Valuation, Quadrupling in Seven Months

AI video generation startup Higgsfield has raised $400 million in a Series B round that values the company at $5.4 billion, up from $1.3 billion in January. The round was led by DST Global with participation from Goldman Sachs, Liberty Global, Intel Capital, and others. The 4x valuation jump in seven months signals intense investor appetite for the AI video layer that could become the foundation for robotics, world models, and the next generation of content creation. What Higgsfield Does Hig

Anthropic in talks to buy Decart for $6 billion, targeting compute efficiency

Anthropic is in talks to acquire Israeli AI startup Decart for about $6 billion, according to people familiar with the matter cited by Bloomberg. The deal would be Anthropic's largest known acquisition and signals a strategic push to lower the cost of running its models at scale. Decart builds software that makes GPU compute more efficient — reducing the cost of training and operating AI models by helping chips work harder. For Anthropic, which just reported preliminary Q2 revenue above $11.5 b

French startup Kog says smarter software can pull 30x faster inference out of stock GPUs

The race for faster AI inference has pushed labs toward custom silicon, but a French startup argues the cheapest speedup is already sitting in servers companies bought. Kog says it can reach roughly thirty times faster LLM inference on standard data-center GPUs using software alone. Kog demonstrated three thousand tokens per second per request on AMD MI300X and NVIDIA H200 GPUs in May, running a small two-billion-parameter model it has since open-sourced as Laneformer 2B. Chief executive Gael D

Blacksmith's valuation jumps nearly 10x in under a year as AI coding fuels software testing

A $45M Series B values the AI code-testing startup at $550M, nearly 10x its year-ago mark.

QuantHealth raises $45M to simulate clinical trials before patients enroll

QuantHealth, a Tel Aviv startup, has raised forty five million dollars in Series B funding to grow its clinical trial simulation platform. Qumra Capital led the round, and the company says total funding now stands near seventy million dollars since its 2020 founding. The pitch is simple to state and hard to achieve: test a trial in software before a single patient is recruited. QuantHealth's tools let drug developers model whether a protocol is likely to succeed, tune who gets included, and est